Cargando…

Friends against the Foe: Synergistic Photothermal and Photodynamic Therapy against Bacterial Infections

Multidrug-resistant (MDR) bacteria are rapidly emerging, coupled with the failure of current antibiotic therapy; thus, new alternatives for effectively treating infections caused by MDR bacteria are required. Hyperthermia-mediated photothermal therapy (PTT) and reactive oxygen species (ROS)-mediated...

Descripción completa

Detalles Bibliográficos
Autores principales: Naskar, Atanu, Kim, Kwang-sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146283/
https://www.ncbi.nlm.nih.gov/pubmed/37111601
http://dx.doi.org/10.3390/pharmaceutics15041116
_version_ 1785034543877586944
author Naskar, Atanu
Kim, Kwang-sun
author_facet Naskar, Atanu
Kim, Kwang-sun
author_sort Naskar, Atanu
collection PubMed
description Multidrug-resistant (MDR) bacteria are rapidly emerging, coupled with the failure of current antibiotic therapy; thus, new alternatives for effectively treating infections caused by MDR bacteria are required. Hyperthermia-mediated photothermal therapy (PTT) and reactive oxygen species (ROS)-mediated photodynamic therapy (PDT) have attracted extensive attention as antibacterial therapies owing to advantages such as low invasiveness, low toxicity, and low likelihood of causing bacterial resistance. However, both strategies have notable drawbacks, including the high temperature requirements of PTT and the weak ability of PDT-derived ROS to penetrate target cells. To overcome these limitations, a combination of PTT and PDT has been used against MDR bacteria. In this review, we discuss the unique benefits and limitations of PTT and PDT against MDR bacteria. The mechanisms underlying the synergistic effects of the PTT–PDT combination are also discussed. Furthermore, we introduced advancements in antibacterial methods using nano-based PTT and PDT agents to treat infections caused by MDR bacteria. Finally, we highlight the existing challenges and future perspectives of synergistic PTT–PDT combination therapy against infections caused by MDR bacteria. We believe that this review will encourage synergistic PTT- and PDT-based antibacterial research and can be referenced for future clinical applications.
format Online
Article
Text
id pubmed-10146283
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101462832023-04-29 Friends against the Foe: Synergistic Photothermal and Photodynamic Therapy against Bacterial Infections Naskar, Atanu Kim, Kwang-sun Pharmaceutics Review Multidrug-resistant (MDR) bacteria are rapidly emerging, coupled with the failure of current antibiotic therapy; thus, new alternatives for effectively treating infections caused by MDR bacteria are required. Hyperthermia-mediated photothermal therapy (PTT) and reactive oxygen species (ROS)-mediated photodynamic therapy (PDT) have attracted extensive attention as antibacterial therapies owing to advantages such as low invasiveness, low toxicity, and low likelihood of causing bacterial resistance. However, both strategies have notable drawbacks, including the high temperature requirements of PTT and the weak ability of PDT-derived ROS to penetrate target cells. To overcome these limitations, a combination of PTT and PDT has been used against MDR bacteria. In this review, we discuss the unique benefits and limitations of PTT and PDT against MDR bacteria. The mechanisms underlying the synergistic effects of the PTT–PDT combination are also discussed. Furthermore, we introduced advancements in antibacterial methods using nano-based PTT and PDT agents to treat infections caused by MDR bacteria. Finally, we highlight the existing challenges and future perspectives of synergistic PTT–PDT combination therapy against infections caused by MDR bacteria. We believe that this review will encourage synergistic PTT- and PDT-based antibacterial research and can be referenced for future clinical applications. MDPI 2023-03-31 /pmc/articles/PMC10146283/ /pubmed/37111601 http://dx.doi.org/10.3390/pharmaceutics15041116 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Naskar, Atanu
Kim, Kwang-sun
Friends against the Foe: Synergistic Photothermal and Photodynamic Therapy against Bacterial Infections
title Friends against the Foe: Synergistic Photothermal and Photodynamic Therapy against Bacterial Infections
title_full Friends against the Foe: Synergistic Photothermal and Photodynamic Therapy against Bacterial Infections
title_fullStr Friends against the Foe: Synergistic Photothermal and Photodynamic Therapy against Bacterial Infections
title_full_unstemmed Friends against the Foe: Synergistic Photothermal and Photodynamic Therapy against Bacterial Infections
title_short Friends against the Foe: Synergistic Photothermal and Photodynamic Therapy against Bacterial Infections
title_sort friends against the foe: synergistic photothermal and photodynamic therapy against bacterial infections
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146283/
https://www.ncbi.nlm.nih.gov/pubmed/37111601
http://dx.doi.org/10.3390/pharmaceutics15041116
work_keys_str_mv AT naskaratanu friendsagainstthefoesynergisticphotothermalandphotodynamictherapyagainstbacterialinfections
AT kimkwangsun friendsagainstthefoesynergisticphotothermalandphotodynamictherapyagainstbacterialinfections